Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 12Menorrhagia 4Endometriosis 1

Interventions

relugolix 2vilaprisan 1cetrorelix 1Triptorelin Pamoate 1Transcranial Direct Current Stimulation 1Sutures 1Surgical Instruments 1Rocuronium 1Robotic Surgical Procedures 1Radiotherapy 1Radiation 1Menotropins 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Indocyanine Green 1Immunonutrition Diet 1Hysterectomy 1Gonadotropins 1Gonadotropin-Releasing Hormone 1Fluconazole 1Endoscopes 1Electrocoagulation 1Danazol 1Chorionic Gonadotropin 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Endometriosis × vilaprisan × Clear all
NCT03411980 2019-12-03

Pharmacokinetics and Safety of Vilaprisan in Renal Impairment

Bayer

Phase 1 Completed
26 enrolled

Endometriosis, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡